SLC16A1 and Burkitt lymphoma: In diffused large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) cell lines, inhibition of MCT1 by the antagonists such as AZD3965, AR-C122982 (as known as SR13800), and AR-C155858 (as known as SR13801), can intercept lactate efflux for the sake of intracellular acidification and thereby, delay tumor lymphoma growth [200,201,202,203].